RIMEGEPANT SULFATE
| Brand name | NURTEC ODT |
|---|---|
| Active ingredient | RIMEGEPANT SULFATE |
| Strength | EQ 75MG BASE |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11083724 | March 2039 | product |
| 8314117 | February 2034 | substance, product |
| 8759372 | February 2033 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.